-
1.
公开(公告)号:US07696223B2
公开(公告)日:2010-04-13
申请号:US11696549
申请日:2007-04-04
申请人: Shaojiang Deng , Min Wu , Eric D. Turtle , Wen-Bin Ho , Michael P. Arend , Heng Cheng , Lee A. Flippin
发明人: Shaojiang Deng , Min Wu , Eric D. Turtle , Wen-Bin Ho , Michael P. Arend , Heng Cheng , Lee A. Flippin
IPC分类号: A61K31/435 , C07D471/02
CPC分类号: C07D471/04 , C07D513/04
摘要: The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF).
摘要翻译: 本发明涉及能够调节缺氧诱导因子(HIF)的稳定性和/或活性的新型化合物。
-
公开(公告)号:US20110212959A1
公开(公告)日:2011-09-01
申请号:US13042281
申请日:2011-03-07
申请人: Michael P. Arend , Lee A. Flippin , Min Wu , Eric D. Turtle , Wen-Bin Ho , Shaojiang Deng
发明人: Michael P. Arend , Lee A. Flippin , Min Wu , Eric D. Turtle , Wen-Bin Ho , Shaojiang Deng
IPC分类号: A61K31/5377 , C12N9/99 , A61K31/472 , A61K31/4725 , A61P7/06 , A61P9/10 , A61P11/00 , A61P1/00 , A61P13/12 , A61P9/00 , A61P27/02 , A61P9/04
CPC分类号: C07D217/26 , A61K31/435 , A61K31/44 , A61K31/47 , A61K31/472 , A61K45/06 , C07D405/12 , C07D413/12 , C07D417/12
摘要: The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions. The cyanoisoquinoline compounds of the invention have the following structure:
摘要翻译: 本发明涉及适合用于治疗缺氧诱导因子介导和/或促红细胞生成素相关病症的氰基异喹啉化合物。 本发明的氰基异喹啉化合物具有以下结构:
-
公开(公告)号:US08759373B2
公开(公告)日:2014-06-24
申请号:US13430568
申请日:2012-03-26
申请人: Michael P. Arend , Lee A. Flippin , Min Wu , Eric D. Turtle , Wen-Bin Ho , Shaojiang Deng
发明人: Michael P. Arend , Lee A. Flippin , Min Wu , Eric D. Turtle , Wen-Bin Ho , Shaojiang Deng
IPC分类号: A01N43/42 , A01N43/40 , A61K31/47 , A61K31/435 , A61K31/44
CPC分类号: C07D217/26 , A61K31/435 , A61K31/44 , A61K31/47 , A61K31/472 , A61K45/06 , C07D405/12 , C07D413/12 , C07D417/12
摘要: The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions. The cyanoisoquinoline compounds of the invention have the following structure:
摘要翻译: 本发明涉及适合用于治疗缺氧诱导因子介导和/或促红细胞生成素相关病症的氰基异喹啉化合物。 本发明的氰基异喹啉化合物具有以下结构:
-
公开(公告)号:US20120178755A1
公开(公告)日:2012-07-12
申请号:US13430568
申请日:2012-03-26
申请人: Michael Arend , Lee A. Flippin , Min Wu , Eric D. Turtle , Wen-Bin Ho , Shaojiang Deng
发明人: Michael Arend , Lee A. Flippin , Min Wu , Eric D. Turtle , Wen-Bin Ho , Shaojiang Deng
IPC分类号: A61K31/47 , A61K31/5377 , A61P7/06 , A61K31/4709
CPC分类号: C07D217/26 , A61K31/435 , A61K31/44 , A61K31/47 , A61K31/472 , A61K45/06 , C07D405/12 , C07D413/12 , C07D417/12
摘要: The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions. The cyanoisoquinoline compounds of the invention have the following structure:
摘要翻译: 本发明涉及适合用于治疗缺氧诱导因子介导和/或促红细胞生成素相关病症的氰基异喹啉化合物。 本发明的氰基异喹啉化合物具有以下结构:
-
公开(公告)号:US07928120B2
公开(公告)日:2011-04-19
申请号:US11627906
申请日:2007-01-26
申请人: Michael Arend , Lee A. Flippin , Min Wu , Eric D. Turtle , Wen-Bin Ho , Shaojiang Deng
发明人: Michael Arend , Lee A. Flippin , Min Wu , Eric D. Turtle , Wen-Bin Ho , Shaojiang Deng
IPC分类号: A01N43/42 , A01N43/40 , A61K31/47 , A61K31/435 , A61K31/44
CPC分类号: C07D217/26 , A61K31/435 , A61K31/44 , A61K31/47 , A61K31/472 , A61K45/06 , C07D405/12 , C07D413/12 , C07D417/12
摘要: The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions. The cyanoisoquinoline compounds of the invention have the following structure:
摘要翻译: 本发明涉及适合用于治疗缺氧诱导因子介导和/或促红细胞生成素相关病症的氰基异喹啉化合物。 本发明的氰基异喹啉化合物具有以下结构:
-
公开(公告)号:US08916585B2
公开(公告)日:2014-12-23
申请号:US13599161
申请日:2012-08-30
申请人: Michael P. Arend , Lee A. Flippin , Volkmar Guenzler-Pukall , Wen-Bin Ho , Eric D. Turtle , Xiaohui Du
发明人: Michael P. Arend , Lee A. Flippin , Volkmar Guenzler-Pukall , Wen-Bin Ho , Eric D. Turtle , Xiaohui Du
IPC分类号: C07D217/24 , A61K31/472 , A61K38/18 , C07D217/26 , C07D401/04 , C07D401/06 , C07D221/08 , C07D401/12 , C07D403/12
CPC分类号: A61K31/472 , A61K31/4725 , A61K31/473 , A61K38/1816 , C07D217/24 , C07D217/26 , C07D221/08 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/12 , A61K2300/00
摘要: The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.
-
公开(公告)号:US20130310565A1
公开(公告)日:2013-11-21
申请号:US13912483
申请日:2013-06-07
申请人: Michael P. Arend , Lee A. Flippin , Volkmar Guenzler-Pukall , Wen-Bin Ho , Eric D. Turtle , Xiaohui Du
发明人: Michael P. Arend , Lee A. Flippin , Volkmar Guenzler-Pukall , Wen-Bin Ho , Eric D. Turtle , Xiaohui Du
IPC分类号: C07D217/26
CPC分类号: A61K31/472 , A61K31/4725 , A61K31/473 , A61K38/1816 , C07D217/24 , C07D217/26 , C07D221/08 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/12 , A61K2300/00
摘要: The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.
-
8.
公开(公告)号:US20120029011A1
公开(公告)日:2012-02-02
申请号:US13186351
申请日:2011-07-19
申请人: Michael P. Arend , Lee A. Flippin , Volkmar Guenzler-Pukall , Wen-Bin Ho , Eric D. Turtle , Xiaohui Du
发明人: Michael P. Arend , Lee A. Flippin , Volkmar Guenzler-Pukall , Wen-Bin Ho , Eric D. Turtle , Xiaohui Du
IPC分类号: A61K31/472 , C07D401/04 , A61P7/00 , A61K31/4725 , A61P7/06 , A61P9/10 , C07D217/26 , C07D401/12
CPC分类号: A61K31/472 , A61K31/4725 , A61K31/473 , A61K38/1816 , C07D217/24 , C07D217/26 , C07D221/08 , C07D401/04 , C07D401/06 , C07D401/12 , C07D403/12 , A61K2300/00
摘要: The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.
摘要翻译: 本发明涉及适用于介导缺氧诱导因子并通过在体外和体内增加内源促红细胞生成素来治疗促红细胞生成素相关病症的化合物。
-
9.
公开(公告)号:US20080004309A1
公开(公告)日:2008-01-03
申请号:US11696549
申请日:2007-04-04
申请人: Shaojiang DENG , Min Wu , Eric Turtle , Wen-Bin Ho , Michael Arend , Heng Cheng , Lee Flippin
发明人: Shaojiang DENG , Min Wu , Eric Turtle , Wen-Bin Ho , Michael Arend , Heng Cheng , Lee Flippin
IPC分类号: A61K31/435 , A61P9/00 , C07D471/02
CPC分类号: C07D471/04 , C07D513/04
摘要: The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF).
摘要翻译: 本发明涉及能够调节缺氧诱导因子(HIF)的稳定性和/或活性的新型化合物。
-
公开(公告)号:US20100047367A1
公开(公告)日:2010-02-25
申请号:US12544861
申请日:2009-08-20
申请人: Shaojiang Deng , Wen-Bin Ho , Lee A. Flippin
发明人: Shaojiang Deng , Wen-Bin Ho , Lee A. Flippin
IPC分类号: A61K31/5025 , C07D487/04 , A61K31/714 , A61K31/519 , A61K33/26 , A61K38/22 , A61P9/10 , A61P9/00 , A61P13/12 , A61P7/06 , C12N9/99
CPC分类号: C07D487/04
摘要: The present invention relates to novel compounds capable of modulating the stability and/or activity of hypoxia inducible factor (HIF) by inhibiting the activity of at least one HIF hydroxylase enzyme.
摘要翻译: 本发明涉及能够通过抑制至少一种HIF羟化酶的活性来调节缺氧诱导因子(HIF)的稳定性和/或活性的新型化合物。
-
-
-
-
-
-
-
-
-